Osper Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.00 Cr
- Revenue Growth -38.07%
- Profit Growth 2.19%
- Ebitda -0.31%
- Net Worth 1.50%
- Total Assets 21.49%
About Osper Formulations
Osper Formulations Private Limited (OFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 June 2013 and has a history of 11 years and eight months. Its registered office is in Rohtak, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹18.00 Cr.
Suresh Gupta and Raj Gupta serve as directors at the Company.
Company Details
- Location
Rohtak, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100HR2013PTC049505
- Company No.
049505
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jun 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Osper Formulations Private Limited offer?
Osper Formulations Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Osper Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Gupta  | Director | 10-Jun-2013 | Current |
| Raj Gupta | Director | 10-Jun-2013 | Current |
Financial Performance of Osper Formulations.
Osper Formulations Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 38.07% decrease. The company also saw a slight improvement in profitability, with a 2.19% increase in profit. The company's net worth moved up by a moderate rise of 1.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Osper Formulations?
In 2023, Osper Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹18.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 8.20 Cr
- Others : 7.58 Cr
- Sidbi : 2.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Feb 2024 | Sidbi | ₹2.22 Cr | Open |
| 18 Aug 2022 | Others | ₹5.70 Cr | Open |
| 14 Dec 2021 | Others | ₹4.70 M | Open |
| 11 Jun 2020 | Others | ₹9.40 M | Open |
| 18 Apr 2020 | Others | ₹4.70 M | Open |
How Many Employees Work at Osper Formulations?
Osper Formulations has a workforce of 12 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Osper Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Osper Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.